| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of Novel Cytotoxic Agents in Lung Cancer: Epothilones and Topoisomerase I Inhibitors
|
Wakelee, Heather A.
|
|
2005
|
|
S1 |
p. S6-S12
7 p.
|
artikel
|
| 2 |
Adjuvant Systemic Therapies in Early-Stage Non–Small-Cell Lung Cancer
|
Schiller, Joan H.
|
|
2003
|
|
S1 |
p. S29-S35
7 p.
|
artikel
|
| 3 |
A Phase I Trial of Outpatient Weekly Docetaxel and Concurrent Radiation Therapy for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbuilt Cancer Center Affiliate Network (VCCAN) Trial
|
Choy, H.
|
|
2000
|
|
S1 |
p. S27-S31
5 p.
|
artikel
|
| 4 |
Biologically Targeted Treatment of Non–Small-Cell Lung Cancer: Focus on Epidermal Growth Factor Receptor
|
Natale, Ronald B.
|
|
2003
|
|
S1 |
p. S11-S17
7 p.
|
artikel
|
| 5 |
Chemotherapy Regimens in Advanced Non–Small-Cell Lung Cancer: Implications and Future Perspectives
|
Belani, Chandra P.
|
|
2000
|
|
S1 |
p. S7-S10
4 p.
|
artikel
|
| 6 |
Chemotherapy Regimens in Advanced non—small-Cell Lung Cancer: Recent Randomized Trials
|
Belani, Chandra P.
|
|
2002
|
|
S1 |
p. S5-S9
5 p.
|
artikel
|
| 7 |
Combinations of Three Chemotherapeutic Agents and Two Chemotherapeutic Agents Plus a Targeted Biologic Agent in the Treatment of Advanced Non–Small-Cell Lung Cancer
|
Bunn Jr., Paul A.
|
|
2000
|
|
S1 |
p. S23-S28
6 p.
|
artikel
|
| 8 |
Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling in Non–Small-Cell Lung Cancer Therapy
|
Pakkala, Suchita
|
|
2009
|
|
S1 |
p. S17-S23
7 p.
|
artikel
|
| 9 |
Combined-Modality Therapy for Inoperable non—small-Cell Lung Cancer Using Gemcitabine
|
Curran Jr., Walter John
|
|
2002
|
|
S1 |
p. S17-S21
5 p.
|
artikel
|
| 10 |
Current State of Vaccine Therapies in Non–Small-Cell Lung Cancer
|
Romero, Pedro
|
|
2008
|
|
S1 |
p. S28-S36
9 p.
|
artikel
|
| 11 |
Current Status of Mammalian Target of Rapamycin Inhibitors in Lung Cancer
|
Gómez-Martín, Carlos
|
|
2005
|
|
S1 |
p. S13-S18
6 p.
|
artikel
|
| 12 |
Current Therapeutic Approaches in Lung Cancer
|
Bunn Jr., Paul A
|
|
2002
|
|
S1 |
p. S4-
1 p.
|
artikel
|
| 13 |
Docetaxel and Gemcitabine: A Nonplatinum Combination for Non–Small-Cell Lung Cancer
|
Olszanski, Anthony J.
|
|
2000
|
|
S1 |
p. S15-S19
5 p.
|
artikel
|
| 14 |
Docetaxel and Gemcitabine Combinations in Chemotherapy-Pretreated Non–Small-Cell Lung Cancer
|
Spiridonidis, C. Harris
|
|
2000
|
|
S1 |
p. S20-S23
4 p.
|
artikel
|
| 15 |
Docetaxel in Combination with Platinum Compounds for Non–Small-Cell Lung Cancer
|
Belani, Chandra P.
|
|
2000
|
|
S1 |
p. S10-S14
5 p.
|
artikel
|
| 16 |
Early Clinical Trial Experience with Vaccine Therapies in Non–Small-Cell Lung Cancer
|
Ho, Cheryl
|
|
2008
|
|
S1 |
p. S20-S27
8 p.
|
artikel
|
| 17 |
Effect of Epidermal Growth Factor Receptor Mutations on the Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Target-Based Populations for Target-Based Drugs
|
Calvo, Emiliano
|
|
2004
|
|
S1 |
p. S35-S42
8 p.
|
artikel
|
| 18 |
Emerging Data with Antiangiogenic Therapies in Early and Advanced Non–Small-Cell Lung Cancer
|
Horn, Leora
|
|
2009
|
|
S1 |
p. S7-S16
10 p.
|
artikel
|
| 19 |
Emerging Novel Agents with Utility in Non–Small-Cell Lung Cancer
|
Belani, Chandra P.
|
|
2005
|
|
S1 |
p. S4-S5
2 p.
|
artikel
|
| 20 |
Emerging Role of Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer
|
Belani, Chandra P.
|
|
2004
|
|
S1 |
p. S6-
1 p.
|
artikel
|
| 21 |
Extending Outcomes: Epidermal Growth Factor Receptor–Targeted Monoclonal Antibodies in Non–Small-Cell Lung Cancer
|
Joy, Anil A.
|
|
2009
|
|
S1 |
p. S24-S29
6 p.
|
artikel
|
| 22 |
Future Randomized Trials for Non–Small-Cell Lung Cancer
|
Green, Mark R.
|
|
2000
|
|
S1 |
p. S29-S32
4 p.
|
artikel
|
| 23 |
Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Review
|
Masters, Gregory A.
|
|
2000
|
|
S1 |
p. S11-S14
4 p.
|
artikel
|
| 24 |
Gemcitabine and Taxane Combinations in Non–Small-Cell Lung Cancer
|
Natale, Ronald B.
|
|
2000
|
|
S1 |
p. S15-S21
7 p.
|
artikel
|
| 25 |
Gemcitabine-Based Doublets for Advanced Non—Small-Cell Lung Cancer: Beyond Gemcitabine/Cisplatin
|
Natale, Ronald B.
|
|
2002
|
|
S1 |
p. S10-S16
7 p.
|
artikel
|
| 26 |
Gemcitabine Plus Radiation Therapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer
|
Ettinger, David S.
|
|
2000
|
|
S1 |
p. S33-S38
6 p.
|
artikel
|
| 27 |
Histone Deacetylase Inhibitors: Emerging Anticancer Therapeutic Agents?
|
Kristeleit, Rebecca
|
|
2005
|
|
S1 |
p. S19-S30
12 p.
|
artikel
|
| 28 |
Immune Modulation as a Therapeutic Strategy for Non–Small-Cell Lung Cancer
|
Holt, Gregory E.
|
|
2008
|
|
S1 |
p. S13-S19
7 p.
|
artikel
|
| 29 |
Interstitial Lung Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Carcinoma
|
Yoneda, Ken Y.
|
|
2006
|
|
S1 |
p. S31-S35
5 p.
|
artikel
|
| 30 |
Irinotecan Combined with Radiation Therapy for Patients with Stage III Non—Small-Cell Lung Cancer: Current Trials
|
Saijo, Nagahiro
|
|
2002
|
|
S1 |
p. S21-S25
5 p.
|
artikel
|
| 31 |
Irinotecan in Non–Small-Cell Lung Cancer: Status of Ongoing Trials
|
Socinski, Mark A.
|
|
2002
|
|
S1 |
p. S15-S20
6 p.
|
artikel
|
| 32 |
Irinotecan in Small-Cell Lung Cancer: Current Data and the Status of Ongoing Trials
|
Sandler, Alan
|
|
2002
|
|
S1 |
p. S30-S34
5 p.
|
artikel
|
| 33 |
Irinotecan/Taxane Combinations in Advanced Non–Small-Cell Lung Cancer
|
Langer, Corey J.
|
|
2002
|
|
S1 |
p. S10-S14
5 p.
|
artikel
|
| 34 |
Managing Dermatologic Toxicities of Epidermal Growth Factor Receptor Inhibitors
|
Chou, Lillian S.
|
|
2006
|
|
S1 |
p. S15-S22
8 p.
|
artikel
|
| 35 |
Molecular Targeted Agents in Non–Small-Cell Lung Cancer
|
Sandler, Alan B.
|
|
2003
|
|
S1 |
p. S22-S28
7 p.
|
artikel
|
| 36 |
Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
|
Lacouture, Mario E.
|
|
2006
|
|
S1 |
p. S36-S42
7 p.
|
artikel
|
| 37 |
Novel Targeted Agents for Lung Cancer
|
West, Howard (Jack)
|
|
2009
|
|
S1 |
p. S41-S46
6 p.
|
artikel
|
| 38 |
Novel Targeted Therapies: A Challenge for Drug Development
|
Belani, Chandra P.
|
|
2003
|
|
S1 |
p. S4-
1 p.
|
artikel
|
| 39 |
Novel Taxane Formulations and Microtubule-Binding Agents in Non–Small-Cell Lung Cancer
|
Edelman, Martin J.
|
|
2009
|
|
S1 |
p. S30-S34
5 p.
|
artikel
|
| 40 |
Novel Therapies for Non–Small-Cell Lung Cancer: A 2008 Update
|
Bunn Jr, Paul A.
|
|
2009
|
|
S1 |
p. S6-
1 p.
|
artikel
|
| 41 |
Overview of the Current Status of Human Epidermal Growth Factor Receptor Inhibitors in Lung Cancer
|
Herbst, Roy S.
|
|
2004
|
|
S1 |
p. S7-S19
13 p.
|
artikel
|
| 42 |
Pemetrexed (Alimta®): A New Antifolate for non—small-Cell Lung Cancer
|
Ettinger, David S.
|
|
2002
|
|
S1 |
p. S22-S25
4 p.
|
artikel
|
| 43 |
Pharmacokinetic Evaluation of Gefitinib When Administered with Chemotherapy
|
Hammond, Lisa A.
|
|
2003
|
|
S1 |
p. S18-S21
4 p.
|
artikel
|
| 44 |
Phase II Clinical Trial Data with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer
|
Pérez-Soler, Romàn
|
|
2004
|
|
S1 |
p. S20-S23
4 p.
|
artikel
|
| 45 |
Predictors of Sensitivity and Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Perea, Sofia
|
|
2004
|
|
S1 |
p. S30-S34
5 p.
|
artikel
|
| 46 |
Primary and Secondary Prevention of Non–Small-Cell Lung Cancer: The SPORE Trials of Lung Cancer Prevention
|
Khuri, Fadlo Raja
|
|
2003
|
|
S1 |
p. S36-S40
5 p.
|
artikel
|
| 47 |
Rash as a Surrogate Marker for Efficacy of Epidermal Growth Factor Receptor Inhibitors in Lung Cancer
|
Perez-Soler, Roman
|
|
2006
|
|
S1 |
p. S7-S14
8 p.
|
artikel
|
| 48 |
Role of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Bronchoalveolar Carcinoma
|
Patel, Jyoti D.
|
|
2004
|
|
S1 |
p. S43-S47
5 p.
|
artikel
|
| 49 |
Select Clinical Trials of Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer with Emphasis on Phase III Outcomes
|
Burgos Fuster, L. Minerva
|
|
2004
|
|
S1 |
p. S24-S29
6 p.
|
artikel
|
| 50 |
Single-Agent Docetaxel (Taxotere®) in the Treatment of Advanced Non–Small-Cell Lung Cancer: Clinical Concepts and Commentary
|
Laurie, Scott A.
|
|
2000
|
|
S1 |
p. S5-S9
5 p.
|
artikel
|
| 51 |
Targeted Therapy Using Novel Agents in the Treatment of Non—Small-Cell Lung Cancer
|
Herbst, Roy S.
|
|
2002
|
|
S1 |
p. S30-S38
9 p.
|
artikel
|
| 52 |
Targeting Angiogenesis with Vascular Endothelial Growth Factor Receptor Small-Molecule Inhibitors: Novel Agents with Potential in Lung Cancer
|
Wakelee, Heather A.
|
|
2005
|
|
S1 |
p. S31-S38
8 p.
|
artikel
|
| 53 |
Targeting Multiple Signal Transduction Pathways in Lung Cancer
|
Adjei, Alex A.
|
|
2005
|
|
S1 |
p. S39-S44
6 p.
|
artikel
|
| 54 |
The Evolving Role of Gemcitabine and Pemetrexed (Alimta®) in the Management of Patients with Malignant Mesothelioma
|
Green, Mark R.
|
|
2002
|
|
S1 |
p. S26-S29
4 p.
|
artikel
|
| 55 |
The Future of Cancer Vaccines for Non–Small-Cell Lung Cancer: Ongoing Trials
|
Choudhury, Aniruddha
|
|
2008
|
|
S1 |
p. S37-S44
8 p.
|
artikel
|
| 56 |
The Impact of Gefitinib on Epidermal Growth Factor Receptor Signaling Pathways in Cancer
|
Averbuch, Steven D.
|
|
2003
|
|
S1 |
p. S5-S10
6 p.
|
artikel
|
| 57 |
The Quest for an Efficacious Lung Cancer Vaccine
|
Murray, Nevin
|
|
2008
|
|
S1 |
p. S4-S5
2 p.
|
artikel
|
| 58 |
Therapeutic Ratio of Targeted Therapies in Non–Small-Cell Lung Cancer
|
Gandara, David R.
|
|
2006
|
|
S1 |
p. S6-
1 p.
|
artikel
|
| 59 |
Therapy of Advanced Non–Small-Cell Lung Cancer with Irinotecan and Gemcitabine in Combination
|
de Freitas, Juliana Ribeiro
|
|
2002
|
|
S1 |
p. S26-S29
4 p.
|
artikel
|
| 60 |
The Role of Irinotecan Combined with Cisplatin or Carboplatin in the Treatment of Advanced Non—Small-Cell Lung Cancer
|
Bunn Jr, Paul A.
|
|
2002
|
|
S1 |
p. S5-S9
5 p.
|
artikel
|
| 61 |
Toxicities of Antiangiogenic Therapy in Non–Small-Cell Lung Cancer
|
Herbst, Roy S.
|
|
2006
|
|
S1 |
p. S23-S30
8 p.
|
artikel
|
| 62 |
Trials of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer
|
Miller, Vincent A.
|
|
2000
|
|
S1 |
p. S24-S26
3 p.
|
artikel
|
| 63 |
Unmet Need in Lung Cancer: Can Vaccines Bridge the Gap?
|
Kim, Jae
|
|
2008
|
|
S1 |
p. S6-S12
7 p.
|
artikel
|
| 64 |
Updated Clinical Information on Multitargeted Antifolates in Lung Cancer
|
Scagliotti, Giorgio V.
|
|
2009
|
|
S1 |
p. S35-S40
6 p.
|
artikel
|
Tijdschrift beschrijving